InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,051.29
(
0.66%
)
US TECH 100
17,016.00
(
0.92%
)
Dow Jones
38,148.86
(
0.65%
)
Brent Oil
83.51
(
-0.04%
)
Bitcoin
59,179.18
(
1.60%
)
Post# of 3353
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

sokol

Send PM Follow Ignore
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

sokol

Re: None

Wednesday, 11/18/2020 4:41:59 PM

Wednesday, November 18, 2020 4:41:59 PM

Post# of 3353
Conference call: Here is a link to sign in to listen to yesterday’s conference call about the NurOwn results. https://www.webcaster4.com/Webcast/Page/2354/38723

I am mystified about the placebo results; however, I am encouraged about the results amongst the specified group, which indicates that NurOwn may be effective if the drug is administered at early onset of ALS. I am also intrigued about the biomarker outcome, which was positive for the treated patients and non-existent in those receiving the placebo. Treated patients exhibited a significant increase of neurotrophic factors and reduction in neurodegenerative and neuroinflammatory biomarkers.

Will the FDA approve the drug for patients that fall in the pre-specified group? Will the FDA require further study for this group?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BCLI News
More BCLI News
InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!